Form 4 for INSM INSMED Inc
Accepted 2024-09-16 00:00:00 ET · period of report 2024-09-12 · accession 0001628280-24-040521 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| DM | 2024-09-16 | 2024-09-12+ | INSM | Flammer Martina M.D. | Chief Medical Off | S - Sale+OE | $74.91 | -41.0K | 106.1K | -28% | -$3.07M |
| DM | 2024-09-16 | 2024-09-12+ | INSM | Flammer Martina M.D. | Chief Medical Off | M - OptEx | $34.03 | +41.0K | 119.6K | +52% | +$1.40M |
| DM | 2024-09-16 | 2024-09-12+ | INSM | Flammer Martina M.D. | Chief Medical Off | M - OptEx | $0.00 | -41.0K | 54.1K | -43% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2024-09-12 | S | D | 635 | $74.92 | 106,134 | D | — | — | (F2) This is the weighted average sales price representing 635 shares sold at prices ranging from $74.90 to $74.93 per share. The reporting person undertakes to provide to the SEC staff, the issuer, or a security holder of the issuer the number of shares sold at each price within the price range upon request. |
| 2 | Common | Common Stock | 2024-09-12 | M | A | 635 | $34.03 | 106,769 | D | — | — | |
| 3 | Common | Common Stock | 2024-09-13 | M | A | 26,969 | $34.03 | 133,103 | D | — | — | |
| 4 | Common | Common Stock | 2024-09-13 | S | D | 26,969 | $74.90 | 106,134 | D | — | — | |
| 5 | Common | Common Stock | 2024-09-16 | M | A | 13,436 | $34.03 | 119,570 | D | — | — | |
| 6 | Common | Common Stock | 2024-09-16 | S | D | 13,436 | $74.92 | 106,134 | D | — | — | (F3) This is the weighted average sales price representing 13,436 shares sold at prices ranging from $74.90 to $75.17 per share. The reporting person undertakes to provide to the SEC staff, the issuer, or a security holder of the issuer the number of shares sold at each price within the price range upon request. |
| 7 | Derivative | Stock Option (right to buy) | 2024-09-16 | M | D | 13,436 | $0.00 | 13,680 | D | $34.03 · — to 2031-01-07 | 13,436 Common Stock | (F4) The options become exercisable based on the following vesting schedule: 25% vest on the first anniversary of the grant date and an additional 12.5% vest on each sixth month anniversary date thereafter through the fourth anniversary of the date of grant. |
| 8 | Derivative | Stock Option (right to buy) | 2024-09-13 | M | D | 26,969 | $0.00 | 27,116 | D | $34.03 · — to 2031-01-07 | 26,969 Common Stock | (F4) The options become exercisable based on the following vesting schedule: 25% vest on the first anniversary of the grant date and an additional 12.5% vest on each sixth month anniversary date thereafter through the fourth anniversary of the date of grant. |
| 9 | Derivative | Stock Option (right to buy) | 2024-09-12 | M | D | 635 | $0.00 | 54,085 | D | $34.03 · — to 2031-01-07 | 635 Common Stock | (F4) The options become exercisable based on the following vesting schedule: 25% vest on the first anniversary of the grant date and an additional 12.5% vest on each sixth month anniversary date thereafter through the fourth anniversary of the date of grant. |